Our deep tech investments target critical and transformative wireless systems based on foundational semiconductor technologies. We focus on enabling breakthroughs needed for next level performance and power efficiency. Targeting AI heavy applications like humanoid robot, space-based communication platforms, full self-drive (FSD) automotive applications, and IOT. We invest where hardware innovation unlocks and enables next generation applications and communication systems.  

We invest in novel approaches in immune modulation, creating next generation treatments for chronic conditions. Our focus is on drugs that address the root causes of chronic inflammation, like autoimmune disorders, allergic and heart disease. These critical conditions affect hundreds of millions of patients who currently only get symptom relief. We back companies pioneering therapies that restore immune balance rather than merely suppress symptoms. We are specializing in drugs that help patients exit chronic conditions and put them on the road to recovery.